We are live on ! Find out more
FFVM

Founders Fund VII Management Portfolio holdings

AUM $2.03M
1-Year Est. Return 72.34%
This Fund
S&P 500
This Quarter Est. Return
+23.53%
1 Year Est. Return
+72.34%
3 Year Est. Return
-64.66%
5 Year Est. Return
-90.66%
10 Year Est. Return
AUM
$24M
AUM Growth
+$4.57M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABCL icon
1
AbCellera Biologics
ABCL
$3.99B
$21.5M 89.83%
3,773,530
CMPS
2
Compass Pathways
CMPS
$2.04B
$2.44M 10.17%
278,880

Similar funds

Founders Fund VII Management's Q4 2023 Portfolio in Review

As of Q4 2023, Founders Fund VII Management held 2 positions worth $24M, up 24% from $19.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 0%. Founders Fund VII Management opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Founders Fund VII Management's ten largest holdings make up 100% of its $24M portfolio in Q4 2023.
  • Founders Fund VII Management opened 0 new positions and closed 0 in Q4 2023.
  • Founders Fund VII Management's portfolio value rose 24% quarter-over-quarter to $24M.

Based on Founders Fund VII Management's 13F filing for Q4 2023, filed 14 Feb 2024.